| IGF1R | InsR | TK | 3qqu | D | | n~2~-[3-methoxy-4-(morpholin-4-yl)phenyl]-n~4~-(quinolin-3-yl)pyrimidine-2,4-diamine | Human | 997 | 0.52 | |
| IGF1R | InsR | TK | 3qqu | B | | n~2~-[3-methoxy-4-(morpholin-4-yl)phenyl]-n~4~-(quinolin-3-yl)pyrimidine-2,4-diamine | Human | 1020 | 0.52 | |
| IGF1R | InsR | TK | 3qqu | C | | n~2~-[3-methoxy-4-(morpholin-4-yl)phenyl]-n~4~-(quinolin-3-yl)pyrimidine-2,4-diamine | Human | 1014 | 0.52 | |
| IGF1R | InsR | TK | 3qqu | A | | n~2~-[3-methoxy-4-(morpholin-4-yl)phenyl]-n~4~-(quinolin-3-yl)pyrimidine-2,4-diamine | Human | 1024 | 0.52 | |
| FGFR2 | FGFR | TK | 6lvk | B | | n-ethyl-2-[[4-[[4-(4-methylpiperazin-1-yl)-3-(2-morpholin-4-ylethoxy)phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide | Human | 12129 | 0.43 | |
| FGFR2 | FGFR | TK | 6lvl | B | | n-ethyl-2-[[4-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide | Human | 12130 | 0.46 | |
| FGFR2 | FGFR | TK | 6lvk | A | | n-ethyl-2-[[4-[[4-(4-methylpiperazin-1-yl)-3-(2-morpholin-4-ylethoxy)phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide | Human | 12131 | 0.43 | |
| FGFR2 | FGFR | TK | 6lvl | A | | n-ethyl-2-[[4-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide | Human | 12132 | 0.46 | |
| KDR | VEGFR | TK | 3cjf | A | B | n~4~-(3-methyl-1h-indazol-6-yl)-n~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine | Human | 6794 | 0.41 | |
| AURKA (AurA) | Aur | Other | 3up7 | A | | 2-({2-[(4-carboxyphenyl)amino]pyrimidin-4-yl}amino)benzoic acid | Human | 2025 | 0.40 | |
| FGFR3 | FGFR | TK | 6lvm | A | | 2-[[5-[2-(3,5-dimethoxyphenyl)ethyl]-2-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]pyrimidin-4-yl]amino]-n-ethyl-benzenesulfonamide | Human | 12134 | 0.40 | |
| FGFR3 | FGFR | TK | 7dhl | A | | 5-[2-(3,5-dimethoxyphenyl)ethyl]-n-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidin-2-amine | Human | 13258 | 0.44 | |
| CLK1 | CLK | CMGC | 7ak3 | A | A | ~{n}-[3-fluoranyl-4-(4-methylpiperazin-1-yl)phenyl]-4-pyrazolo[1,5-b]pyridazin-3-yl-pyrimidin-2-amine | Human | 13142 | 0.43 | |
| KDR | VEGFR | TK | 3cjf | A | A | n~4~-(3-methyl-1h-indazol-6-yl)-n~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine | Human | 6792 | 0.41 | |
| CLK1 | CLK | CMGC | 7ak3 | A | B | ~{n}-[3-fluoranyl-4-(4-methylpiperazin-1-yl)phenyl]-4-pyrazolo[1,5-b]pyridazin-3-yl-pyrimidin-2-amine | Human | 13143 | 0.43 | |
| DYRK1A | DYRK | CMGC | 8c3g | A | B | n-[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]-4-(1-methylpyrrolo[2,3-c]pyridin-3-yl)pyrimidin-2-amine | Human | 15153 | 0.40 | |
| DYRK1A | DYRK | CMGC | 8c3g | A | A | n-[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]-4-(1-methylpyrrolo[2,3-c]pyridin-3-yl)pyrimidin-2-amine | Human | 15155 | 0.40 | |
| DYRK1B | DYRK | CMGC | 8c2z | A | A | n-[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]-4-(1-methylpyrrolo[2,3-c]pyridin-3-yl)pyrimidin-2-amine | Human | 15180 | 0.40 | |
| DYRK1B | DYRK | CMGC | 8c2z | A | B | n-[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]-4-(1-methylpyrrolo[2,3-c]pyridin-3-yl)pyrimidin-2-amine | Human | 15181 | 0.40 | |
Match: